Discovery of a Nanomolar Inhibitor of the Human Murine Double Minute 2 (MDM2)−p53 Interaction through an Integrated, Virtual Database Screening Strategy
Authors:
- 26 May 2006
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 49 (13) , 3759-3762
Abstract
An integrated, virtual database screening strategy has led to 7-[anilino(phenyl)methyl]-2-methyl-8-quinolinol (4, NSC 66811) as a novel inhibitor of the murine double minute 2 (MDM2)-p53 interaction. This quinolinol binds to MDM2 with a Ki of 120 nM and activates p53 in cancer cells with a mechanism of action consistent with targeting the MDM2-p53 interaction. It mimics three p53 residues critical in the binding to MDM2 and represents a promising new class of non-peptide inhibitors of the MDM2-p53 interaction.Keywords
This publication has 18 references indexed in Scilit:
- p53 Activation by Small Molecules: Application in OncologyJournal of Medicinal Chemistry, 2005
- Discovery and Cocrystal Structure of Benzodiazepinedione HDM2 Antagonists That Activate p53 in CellsJournal of Medicinal Chemistry, 2005
- An Extensive Test of 14 Scoring Functions Using the PDBbind Refined Set of 800 Protein−Ligand ComplexesJournal of Chemical Information and Computer Sciences, 2004
- A Nonpeptidic Sulfonamide Inhibits the p53−mdm2 Interaction and Activates p53-Dependent Transcription in mdm2-Overexpressing CellsJournal of Medicinal Chemistry, 2004
- In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2Science, 2004
- Improved protein–ligand docking using GOLDProteins: Structure, Function, and Bioinformatics, 2003
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- MDM2 — master regulator of the p53 tumor suppressor proteinGene, 2000
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation DomainScience, 1996